TC BioPharm (Holdings) PLC (TCBP)

1.15 +0.08 (+7.48%) USD  |  NASDAQ  |  Nov 12, 15:11
More

TC BioPharm Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for TCBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2022 --
December 31, 2021 --
Date Value
December 31, 2020 --
December 31, 2019 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

Upgrade
Minimum
2022
Upgrade
Maximum
2020
Upgrade
Average
Upgrade
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
Verona Pharma PLC --
NuCana PLC --
Autolus Therapeutics PLC Upgrade